What are the side effects of nintedanib?

Nintedanib (Nintedanib) is a drug targeting idiopathic pulmonary fibrosis and other related diseases, and its side effects have been gradually recognized and summarized in clinical use.

First of all, diarrhea is one of the most common side effects of nintedanib. Patients may experience mild to moderate diarrhea during taking it, which usually appears within a few days after the start of treatment. In severe cases, it may even lead to dehydration or electrolyte imbalance. In addition, nausea and vomiting are frequently reported side effects, and these symptoms may affect patients' quality of life, resulting in decreased appetite and weight loss.

In addition to digestive side effects, nintedanib may also cause liver function abnormalities. Drug-induced liver injury has been observed in some patients, manifesting as elevated liver enzymes, so liver function needs to be monitored regularly during treatment. The risk in this regard prompts doctors to carefully assess patients' underlying health conditions when prescribing, especially those with a history of liver disease.

Another side effect that needs attention is bleeding. Some patients may experience varying degrees of bleeding events after using nintedanib, including nose bleeding, gum bleeding, etc. In severe cases, gastrointestinal bleeding may occur. This situation needs to be dealt with promptly and consideration should be given to adjusting the medication regimen.

In addition, nintedanib may cause proteinuria, which is an abnormal amount of protein in the urine, which can be clearly detected during a urine test. Pancreatitis is also a side effect that a small number of patients may experience, manifesting as abdominal pain, nausea and other symptoms. In severe cases, hospitalization may be required. Allergic reactions such as rash and itching have also been reported. Although relatively rare, they will have a certain impact on the patient's psychological and physiological state.

Finally, nintedanib has certain contraindications, especially patients who are allergic to the drug or its components, as well as pregnant women, who should avoid using this drug. The emergence of these side effects emphasizes the need to maintain good communication between doctors and patients and closely monitor drug responses when using nintedanib treatment, so as to adjust the treatment plan in a timely manner and improve patient safety and treatment.

Reference materials:https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=da1c9f37-779e-4682-816f-93d0faa4cfc9